- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Tenax Therapeutics (TENX)
Company Profile
Quarter (USD) | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 111.45 mm | 111.45 mm | 111.45 mm | 111.45 mm | 111.45 mm | 111.45 mm |
Cash burn (monthly) | (no burn) | (no burn) | 3.78 mm | 2.90 mm | 2.32 mm | 1.38 mm |
Cash used (since last report) | n/a | n/a | 10.43 mm | 7.99 mm | 6.41 mm | 3.82 mm |
Cash remaining | n/a | n/a | 101.02 mm | 103.46 mm | 105.04 mm | 107.63 mm |
Runway (months of cash) | n/a | n/a | 26.7 | 35.7 | 45.2 | 77.7 |
13F holders | Current |
---|---|
Total holders | 28 |
Opened positions | 13 |
Closed positions | 3 |
Increased positions | 1 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 8.46 bn |
Total shares | 9.49 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Vivo Opportunity Fund | 6.25 mm | $25.88 mm |
Intracoastal Capital | 479.73 k | $840.00 k |
Adage Capital Management | 369.10 k | $1.59 mm |
Venrock Healthcare Capital Partners III | 355.22 k | $1.47 mm |
Biotechnology Value Fund L P | 340.66 k | $1.41 mm |
BVF | 339.55 k | $2.10 bn |
Dellora Investments | 234.79 k | $1.48 mm |
VR Adviser | 208.33 k | $1.29 bn |
Vivo Capital | 208.33 k | $1.29 bn |
JHG Janus Henderson | 166.67 k | $1.03 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 May 25 | Chrisopher Thomas Giordano | Stock Option Common Stock | Grant | Acquire A | No | No | 5.89 | 1,400,000 | 8.25 mm | 1,400,000 |
16 May 25 | Stuart Rich | Stock Option Common Stock | Grant | Acquire A | No | No | 5.89 | 625,000 | 3.68 mm | 625,000 |
10 Dec 24 | June Sherie Almenoff | Stock Option Common Stock | Grant | Acquire A | No | No | 5.94 | 100,000 | 594.00 k | 100,000 |